# Yuanmazhiyao

Developer of circular mRNA-based in vivo CAR-T therapies

Developer of circular mRNA-based in vivo CAR-T therapies

Canonical: https://uniquebase.ai/companies/UB-C10450
Stable identifier: UB-C10450
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T20:35:58.771Z

## Funding

Listed 1 record.

- 2026-07-22 · Tens of millions of RMB · Pre-Series A · 倚锋资本, 英矽智能
  > On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies. (translated source brief)

## Valuation

Listed 1 record.

- 2026-07-22 · amount unavailable · Pre-Series A · 倚锋资本, 英矽智能
  > On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies. (translated source brief)

## Revenue

No revenue records are listed yet.


## Team

- [Zhao Hui](/people/zhao-hui)

## Products

No published products profiles are linked yet.

## Investors

- [倚锋资本](/institutions/UB-I7305)
- [英矽智能](/institutions/yingxi-intelligence)

## Sources

- No source links are available for this profile.